REIMAGINE IMMUNOTHERAPY

What this means for you

Approved and waiting on proof of use. It will register unless the applicant drops it, and its 25 Mar 2026 filing date already counts against anyone who files later.

Record

Serial number

99724695

Mark type

Stylized text

Filed

25 Mar 2026

Published for opposition

29 Sept 2026

Attorney of record

Jeannine Rittenhouse

Goods and services

• Class 005 — Pharmaceuticals: Pharmaceutical preparations for cellular therapy for the treatment of immune system related diseases and disorders, autoimmune diseases, cancer, inflammation and autoinflammation diseases and used in extracorporeal photopheresis, extracorporeal photo immune therapy, extracorporeal photo chemotherapy, cellular therapies, and photopheresis
• Class 010 — Medical apparatus: medical devices, namely, therapeutic medical device for extracting blood from the body, separating blood, treating it extra corporally, and returning it to the body, used for extra corporeal photopheresis, extra corporeal photo immune therapy, extra corporeal photo chemotherapy, and cellular therapies
• Class 044 — Medical, beauty and agricultural services: Medical services, namely, extracorporeal photopheresis, extracorporeal photo immune therapy, extracorporeal photo chemotherapy, cellular therapies, and photopheresis

Owner

• Therakos Holdings USA, LLC, Wilmington, DE, US

Prosecution history

• 03 Sept 2026 — APPROVED FOR PUB - PRINCIPAL REGISTER
• 02 Sept 2026 — TEAS/EMAIL CORRESPONDENCE ENTERED
• 02 Sept 2026 — CORRESPONDENCE RECEIVED IN LAW OFFICE
• 02 Sept 2026 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
• 12 Aug 2026 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
• 12 Aug 2026 — NON-FINAL ACTION E-MAILED
• 12 Aug 2026 — NON-FINAL ACTION WRITTEN
• 05 Aug 2026 — ASSIGNED TO EXAMINER
• 29 Jul 2026 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
• 25 Mar 2026 — APPLICATION FILING RECEIPT MAILED
• 25 Mar 2026 — NEW APPLICATION ENTERED